Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for Thrombocytopenia in HCV
NCT01153919Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Jun 2010
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Thrombocytopenia comparing Romiplostim with Placebo (2 arms). Primary endpoint: Mean platelet count for actively treated and placebo treated subjects. Started Jun 2010; status: terminated.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01153919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01153919.